Results 41 to 50 of about 1,713,919 (291)

Incremental diagnostic role of left atrial strain analysis in thrombotic risk assessment of nonvalvular atrial fibrillation patients planned for electrical cardioversion

The International Journal of Cardiovascular Imaging, 2021
During the COVID-19 pandemic, transesophageal echocardiography (TEE) for left atrial appendage thrombosis (LAAT) detection should be limited to situations of absolute necessity. We sought to identify the main conventional and functional echocardiographic
A. Sonaglioni, M. Lombardo, G. Nicolosi, Elisabetta Rigamonti, C. Anza'   +4 more
semanticscholar   +1 more source

Left atrial appendage thrombus in patients referred to electrical cardioversion for atrial fibrillation: a prospective single-center study.

Polish Archives of Internal Medicine, 2022
INTRODUCTION Left atrial appendage thrombus (LAAT) is a risk factor for stroke; however, the actual health risk associated with LAAT in patients with atrial fibrillation (AF) on chronic anticoagulation is unknown.
Łukasz Turek, M. Sadowski, A. Janion-Sadowska, J. Kurzawski, A. Jaroszyński   +4 more
semanticscholar   +1 more source

Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada.

PLoS ONE, 2022
BackgroundCardioversion of acute-onset atrial fibrillation (AF) via electrical or pharmacological means is a common procedure performed in many emergency departments.
Clare L Atzema, Ian G Stiell, Alice S Chong, Peter C Austin   +3 more
doaj   +2 more sources

Safety concern with electrical cardioversion of persistent atrial fibrillation with slow ventricular response

Pacing and clinical electrophysiology : PACE, 2022
Rhythm control strategies in patients with atrial fibrillation (AF) can bring many clinical benefits. However, there is still uncertainty regarding selection of the optimal rhythm control strategy for persistent AF.
Jino Park, Sang-Hoon Seol, Dong-Kie Kim, Seunghwan Kim, Y. Song, D. Kim, Ki-Hun Kim   +6 more
semanticscholar   +1 more source

Effect of electrical cardioversion on 1‐year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation

Clinical Cardiology, 2021
Atrial fibrillation (AF) recurrence is common in the 3‐month blanking‐period after catheter ablation, during which electrical cardioversion (ECV) is usually performed to restore sinus rhythm.
Zheng Dong, Xin Du, Xiao-Xia Hou, Liu He, Jian-zeng Dong, Changsheng Ma   +5 more
semanticscholar   +1 more source

Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion

Equine Veterinary Journal, 2021
Summary Background The recurrence rate of atrial fibrillation (AF) in horses after cardioversion to sinus rhythm (SR) is relatively high. Atrial fibrillatory rate (AFR) derived from surface ECG is considered a biomarker for electrical remodelling and ...
R. Buhl, E. Hesselkilde, Helena Carstensen, C. Hopster‐Iversen, G. van Loon, A. Decloedt, G. van Steenkiste, C. Marr, V. Reef, C. Schwarzwald, K. Mitchell, K. Nostell, N. Nógrádi, S. Nielsen, J. Carlson, P. Platonov   +15 more
semanticscholar   +1 more source

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm

Journal of Clinical Medicine, 2021
Background: Antiarrhythmic drugs (AADs) are frequently initiated in patients with persistent atrial fibrillation (AF) prior to electrical cardioversion (ECV), achieving pharmacological cardioversion (PCV) in some cases.
Amine El Amrani, X. Viñolas, M. A. Arias, V. Bazan, P. Valdovinos, J. Alegret   +5 more
semanticscholar   +1 more source

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. [PDF]

, 2020
Introduction  This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of ...
Camm, AJ, Cappato, R, Ezekowitz, MD, Hohnloser, SH, Kirchhof, P, Meng, IL, Purmah, Y, Schiffer, S, Schulz, A, Wosnitza, M   +9 more
core   +1 more source

Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]

, 2017
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core   +1 more source

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Anticoagulation is indicated for 4 weeks after cardioversion in patients with atrial fibrillation/flutter. We sought to examine whether there is evidence of sex or racial disparity in anticoagulant prescription following cardioversion, and ...
A. Mentias, S. Nakhla, M. Desai, O. Wazni, V. Menon, S. Kapadia, M. V. Vaughan Sarrazin   +6 more
semanticscholar   +1 more source